Emerging Infectious Disease ISSN: 1080-6059

Borrelia burgdorferi Infection and Cutaneous Lyme Disease, Mexico

Guadalupe Gordillo-Pérez*, Javier Torres*, Fortino Solórzano-Santos*, Sylvie de Martino†, Dan Lipsker†, Edmundo Velázquez*, Guillermo Ramon*, Muñoz Onofre*, and Benoit Jaulhac†

Author affiliations: *Instituto Mexicano del Seguro Social, Mexico City, Mexico; †Hôpitaux Universitaires, Strasbourg, France;

Main Article

Figure 1

Western Blot (WB) immunoglobulin G results from cutaneous cases. A) WB with serum from patient 1, showing erythema migrans (arrow). B) WB with serum from patient 4, showing lymphocytoma (arrow); a strong positive and a weak positive control were included.

Figure 1. Western Blot (WB) immunoglobulin G results from cutaneous cases. A) WB with serum from patient 1, showing erythema migrans (arrow). B) WB with serum from patient 4, showing lymphocytoma (arrow); a strong positive and a weak positive control were included.

Main Article

Top of Page

The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.